CN113727968B - 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法 - Google Patents

4-氧代吡咯烷-3-甲酰胺衍生物的制备方法 Download PDF

Info

Publication number
CN113727968B
CN113727968B CN202080029336.4A CN202080029336A CN113727968B CN 113727968 B CN113727968 B CN 113727968B CN 202080029336 A CN202080029336 A CN 202080029336A CN 113727968 B CN113727968 B CN 113727968B
Authority
CN
China
Prior art keywords
group
groups
formula
compound represented
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080029336.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN113727968A (zh
Inventor
三好启太
神田贵博
小松秀孝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinglin Pharmaceutical Holdings Co ltd
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of CN113727968A publication Critical patent/CN113727968A/zh
Application granted granted Critical
Publication of CN113727968B publication Critical patent/CN113727968B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN202080029336.4A 2019-05-14 2020-05-13 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法 Active CN113727968B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-091100 2019-05-14
JP2019091100 2019-05-14
PCT/JP2020/019047 WO2020230802A1 (ja) 2019-05-14 2020-05-13 4-オキソピロリジン-3-カルボン酸アミド誘導体の製造方法

Publications (2)

Publication Number Publication Date
CN113727968A CN113727968A (zh) 2021-11-30
CN113727968B true CN113727968B (zh) 2024-08-23

Family

ID=73288868

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080029336.4A Active CN113727968B (zh) 2019-05-14 2020-05-13 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法

Country Status (3)

Country Link
JP (2) JPWO2020230802A1 (cg-RX-API-DMAC7.html)
CN (1) CN113727968B (cg-RX-API-DMAC7.html)
WO (1) WO2020230802A1 (cg-RX-API-DMAC7.html)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1701072A (zh) * 2002-09-17 2005-11-23 沃纳-兰伯特公司 用于治疗精神分裂症的杂环取代的哌嗪
CN103228628A (zh) * 2010-10-25 2013-07-31 杏林制药株式会社 制备3,4-双取代的吡咯烷衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060194A (en) * 1960-03-29 1962-10-23 American Cyanamid Co 4-cyano-3-oxo-pyrrolidine carboxylates
EA200500342A1 (ru) * 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
WO2017119503A1 (ja) * 2016-01-08 2017-07-13 株式会社ジーンデザイン ゾル-ゲル法で作製される無機多孔質体を用いた核酸合成用担体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1701072A (zh) * 2002-09-17 2005-11-23 沃纳-兰伯特公司 用于治疗精神分裂症的杂环取代的哌嗪
CN103228628A (zh) * 2010-10-25 2013-07-31 杏林制药株式会社 制备3,4-双取代的吡咯烷衍生物的方法

Also Published As

Publication number Publication date
CN113727968A (zh) 2021-11-30
JPWO2020230802A1 (cg-RX-API-DMAC7.html) 2020-11-19
WO2020230802A1 (ja) 2020-11-19
JP2025114857A (ja) 2025-08-05

Similar Documents

Publication Publication Date Title
CN102712585B (zh) 中性内肽酶抑制剂中间体和其制备方法
JP2024543219A (ja) イソオキサゾリン-5,5-ビニルカルボン酸誘導体の製造方法
KR101030202B1 (ko) 퀴놀론 중간체의 제조를 위한 수소화물 환원 방법
KR20020033617A (ko) 2,2-디메틸-1,3-디옥산 중간체의 염 및 그것의 제조방법
AP1226A (en) Process for the synthesis of hiv protease inhibitors.
CN113727968A (zh) 4-氧代吡咯烷-3-甲酰胺衍生物的制备方法
AU2011204131B2 (en) Method for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof
ES2378856T3 (es) Método de producción de un derivado de ácido quinolonocarboxílico
CN101045695B (zh) 用于制备喹诺酮中间体的氢化还原方法
US8501965B2 (en) Method for producing 3-substituted-4-fluoropyrrolidine derivative
JP4181233B2 (ja) ピロリジン−2,4−ジオン誘導体の製法
US7842818B2 (en) Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
US9108915B2 (en) Method for producing 3,4-disubstituted pyrrolidine derivative
JP2915068B2 (ja) ジヒドロフラノン誘導体の製造方法
NO20024046L (no) Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav
KR100449750B1 (ko) 라세믹 알킬 4-클로로-3-히드록시부티레이트의 제조방법
EP4323333A1 (en) A process for preparation of substituted enamine compounds
EP1257534B1 (en) Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester
WO2004074255A2 (en) Method for producing an optically active tetrahydroquinoline
KR100896087B1 (ko) 광학적으로 순수한 2-메틸피롤리딘 및 그 염의 제조방법
JP2000026457A (ja) 3−アミノチオフェン誘導体の製造方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 3-7 Otemachi 1-chome, Chiyoda ku, Tokyo, Japan

Patentee after: KYORIN PHARMACEUTICAL Co.,Ltd.

Country or region after: Japan

Address before: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee before: Xinglin Pharmaceutical Holdings Co.,Ltd.

Country or region before: Japan

CP03 Change of name, title or address
TR01 Transfer of patent right

Effective date of registration: 20241025

Address after: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee after: Xinglin Pharmaceutical Holdings Co.,Ltd.

Country or region after: Japan

Address before: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee before: KYORIN PHARMACEUTICAL Co.,Ltd.

Country or region before: Japan

TR01 Transfer of patent right